These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8855812)

  • 1. In vivo and in vitro evidence for iodide regulation of major histocompatibility complex class I and class II expression in Graves' disease.
    Schuppert F; Taniguchi S; Schröder S; Dralle H; von zur Mühlen A; Kohn LD
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3622-8. PubMed ID: 8855812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
    Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
    Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kappa B.
    Taniguchi SI; Shong M; Giuliani C; Napolitano G; Saji M; Montani V; Suzuki K; Singer DS; Kohn LD
    Mol Endocrinol; 1998 Jan; 12(1):19-33. PubMed ID: 9440807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole, and iodide as well as interferon.
    Saji M; Moriarty J; Ban T; Singer DS; Kohn LD
    J Clin Endocrinol Metab; 1992 Sep; 75(3):871-8. PubMed ID: 1381373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodide, cytokines and TSH-receptor expression in Graves' disease.
    Schuppert F; Hiller W; Weinland G; Hoang-Vu C; von zur Mühlen A; Kohn LD
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():68-74. PubMed ID: 8981006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased major histocompatibility complex (MHC) expression in nontoxic goiters is associated with iodide depletion, enhanced ability of the follicular thyroglobulin to increase MHC gene expression, and thyroid autoantibodies.
    Schuppert F; Ehrenthal D; Frilling A; Suzuki K; Napolitano G; Kohn LD
    J Clin Endocrinol Metab; 2000 Feb; 85(2):858-67. PubMed ID: 10690902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of methimazole on dendritic cell (DC) function and DC-induced Graves' hyperthyroidism in mice.
    Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
    Autoimmunity; 2007 Jul; 40(5):397-402. PubMed ID: 17612902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin.
    Yamazaki K; Tanigawa K; Suzuki K; Yamada E; Yamada T; Takano K; Obara T; Sato K
    Thyroid; 2010 Jan; 20(1):67-76. PubMed ID: 20025541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered responsiveness to thyrotropin in thyroid slices of Graves' disease preoperatively treated with excess iodide.
    Onaya T; Miyakawa M; Makiuchi M; Furihata R
    J Clin Endocrinol Metab; 1978 Aug; 47(2):405-9. PubMed ID: 233671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose levels increase major histocompatibility complex class I gene expression in thyroid cells and amplify interferon-gamma action.
    Napolitano G; Bucci I; Giuliani C; Massafra C; Di Petta C; Devangelio E; Singer DS; Monaco F; Kohn LD
    Endocrinology; 2002 Mar; 143(3):1008-17. PubMed ID: 11861526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methimazole blocks Graves' IgG but not interferon-gamma HLA-DR expression by thyroid cells.
    Bodolay E; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
    Immunol Lett; 1988 Jul; 18(3):167-71. PubMed ID: 3139552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of major histocompatibility complex gene expression in thyroid epithelial cells by methimazole and phenylmethimazole.
    Giuliani C; Bucci I; Montani V; Singer DS; Monaco F; Kohn LD; Napolitano G
    J Endocrinol; 2010 Jan; 204(1):57-66. PubMed ID: 19837722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta 2-microglobulin in patients with Graves' disease.
    Escobar-Morreale HF; Serrano-Gotarredona J; Villar LM; García-Robles R; González-Porqué P; Sancho JM; Varela C
    Thyroid; 1996 Feb; 6(1):29-36. PubMed ID: 8777381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
    Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
    J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.